The TCGA, CGGA, and GEO cohorts also supported the result that high SYDE1 expression in gliomas is associated with shorter OS time, and decreased levels of SYDE1 expression are associated with longer OS time in glioma patients (p < 0.05, Figures 7C–I). The gene discussed is SYDE1; the disease is glioma.